Literature DB >> 25743265

GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Antonio Ceriello1,2, Lucia La Sala3, Valeria De Nigris3, Gemma Pujadas3, Roberto Testa4, Annachiara Uccellatore5,6, Stefano Genovese5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25743265     DOI： 10.1007/s12020-015-0565-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  17 in total

Review 1.  Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes.

Authors:  Antonio Ceriello
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-05

2.  Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.

Authors:  Hisko Oeseburg; Rudolf A de Boer; Hendrik Buikema; Pim van der Harst; Wiek H van Gilst; Herman H W Silljé
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-06       Impact factor: 8.311

3.  Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.

Authors:  S Uemura; H Matsushita; W Li; A J Glassford; T Asagami; K H Lee; D G Harrison; P S Tsao
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

4.  Cardioprotective effects of exenatide against oxidative stress-induced injury.

Authors:  Guanglei Chang; Dongying Zhang; Hui Yu; Peng Zhang; Ying Wang; Aihua Zheng; Shu Qin
Journal:  Int J Mol Med       Date:  2013-08-27       Impact factor: 4.101

Review 5.  Novel biochemical pathways of endoglin in vascular cell physiology.

Authors:  Carmelo Bernabeu; Barbara A Conley; Calvin P H Vary
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

Review 6.  Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.

Authors:  Sugreev Verma; Kousik Kesh; Nilanjan Ganguly; Sayantan Jana; Snehasikta Swarnakar
Journal:  World J Biol Chem       Date:  2014-08-26

7.  Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients.

Authors:  Ana M Blázquez-Medela; Luis García-Ortiz; Manuel A Gómez-Marcos; José I Recio-Rodríguez; Angel Sánchez-Rodríguez; José M López-Novoa; Carlos Martínez-Salgado
Journal:  BMC Med       Date:  2010-12-20       Impact factor: 8.775

8.  Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study.

Authors:  Gabriella Gruden; Federica Barutta; Nish Chaturvedi; Casper Schalkwijk; Coen D Stehouwer; Daniel R Witte; John H Fuller; Paolo Cavallo Perin; Graziella Bruno
Journal:  Diabetes Care       Date:  2012-05-14       Impact factor: 19.112

9.  Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Authors:  Antonio Ceriello; Anna Novials; Emilio Ortega; Silvia Canivell; Lucia La Sala; Gemma Pujadas; Katherine Esposito; Dario Giugliano; Stefano Genovese
Journal:  Diabetes Care       Date:  2013-04-05       Impact factor: 19.112

10.  Relationship of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability.

Authors:  Jason L Johnson; Nicholas P Jenkins; Wei-Chun Huang; Karina Di Gregoli; Graciela B Sala-Newby; Vincent P W Scholtes; Frans L Moll; Gerard Pasterkamp; Andrew C Newby
Journal:  Mediators Inflamm       Date:  2014-08-24       Impact factor: 4.711
View more
  5 in total

1.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 2.  Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome.

Authors:  Matej Vicen; Ivone Cristina Igreja Sá; Katarína Tripská; Barbora Vitverová; Iveta Najmanová; Samira Eissazadeh; Stanislav Micuda; Petr Nachtigal
Journal:  Cell Mol Life Sci       Date:  2020-11-13       Impact factor: 9.261

3.  Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells.

Authors:  Katarina Tripska; Ivone Cristina Igreja Sá; Martina Vasinova; Matej Vicen; Radim Havelek; Samira Eissazadeh; Zuzana Svobodova; Barbora Vitverova; Charles Theuer; Carmelo Bernabeu; Petr Nachtigal
Journal:  Front Med (Lausanne)       Date:  2022-09-07

4.  Soluble Endoglin Level Increase Occurs Prior to Development of Subclinical Structural Vascular Alterations in Diabetic Adolescents.

Authors:  Hamdi Cihan Emeksiz; Aysun Bideci; Çağrı Damar; Betül Derinkuyu; Nurullah Çelik; Esra Döğer; Özge Yüce; Mehmet Cüneyt Özmen; Mahmut Orhun Çamurdan; Peyami Cinaz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-21

5.  Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.

Authors:  Eunate Gallardo-Vara; Simon Tual-Chalot; Luisa M Botella; Helen M Arthur; Carmelo Bernabeu
Journal:  Dis Model Mech       Date:  2018-09-21       Impact factor: 5.758
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.